EpiPancancer
Commercial- Indications
- Pancreatic cancer
Company intelligence / Profile preview
HKG Epitherapeutics
Hong Konghkgepi.com.hk ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
HKG Epitherapeutics has developed and commercialized several proprietary non-invasive tests for early detection of cancers (liver/hepatocellular carcinoma and cervical) as well as biological age determination. Their clinical validation studies have shown that their DNA methylation marker panels can significantly improve sensitivity and specificity in early-stage hepatocellular carcinoma detection when combined with standard markers like AFP. The company’s CAP-accredited lab in Hong Kong processes samples globally.
- Therapeutic areas
- OncologyPsychiatryOther
- Modalities
- Small molecule (for genetic/epigenetic diagnostics)Diagnostic test
- Industry
- Molecular Diagnostics
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaborates with academic institutions including McGill University through founder Prof. Moshe SzyfSeeking diagnostic licensing partnerships globallyLocated at Hong Kong Science Park Technology Platform
Beyond the preview
Go deeper on HKG Epitherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HKG Epitherapeutics.